Concepedia
Statistics
Publications
5
Citations
747
H-Index
Active since
2000
Affiliations
Atlanta Allergy and Asthma Clinic(Current)
Novartis (Switzerland)
The Royal Free Hospital
Charité - Universitätsmedizin Berlin
Johannes Gutenberg University Mainz
Kate Champain is an author at Atlanta Allergy and Asthma Clinic specializing in pharmacology, allergy, and immunotherapy.
Publications per year
2000–2002
Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen–induced seasonal allergic rhinitis
E Ädelroth, S. Rak, Tari Haahtela et al. · Journal of Allergy and Clinical Immunology · 2000 · 318 citations · Full text
Life Sciences, Immunology, Allergy +15
Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma
Roland Buhl, M. Solèr, Jonathan Matz et al. · European Respiratory Journal · 2002 · 180 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +15
The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma
Roland Buhl, G. Hanf, M. Solèr et al. · European Respiratory Journal · 2002 · 158 citations · Full text
Life Sciences, Pharmacology, Pharmacotherapy +17
Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro.
K. Ganeshaguru, R G Wickremasinghe, Dylan T. Jones et al. · PubMed · 2002 · 52 citations
Medicine, Oncology, Pharmacology +9
A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C
Andres Virchis, K. Ganeshaguru, Dylan T. Jones et al. · The Hematology Journal · 2002 · 39 citations
Medicine, Hematology, Pharmacology +10
1–5 of 5